Droxidopa
NDC 50228-431, droxidopa, capsule, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-431
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DROXIDOPA300 mg/1
Pharmacologic classes
Catecholamines [CS]; Increased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-431-05 | 50228043105 | 500 CAPSULE in 1 BOTTLE (50228-431-05) |
| 50228-431-30 | 50228043130 | 30 CAPSULE in 1 BOTTLE (50228-431-30) |
| 50228-431-90 | 50228043190 | 90 CAPSULE in 1 BOTTLE (50228-431-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/10b02d98-ebb8-4152-bd56-3402417fbf79NADAC price for package 50228043190
GET /v1/drugs/nadac/50228043190
Use it
Look up 50228-431 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-431. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.